ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1446 National Cancer Institute Html en Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)–Patient Version Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.
cancer treatment0.700679
oral mucositis pain0.483396
tissue0.465551
chemotherapy0.631313
blood cell count0.467595
mouth problems0.466009
PDQ Oral Complications0.468892
oral health exam0.469677
mouth sores0.537291
infections0.470414
teeth0.49264
neck radiation therapy0.476468
high-dose chemotherapy0.598756
cancer information summary0.466904
oral mucositis0.510415
stem cell transplant0.72121
oral complications0.763758
patients0.61166
cancer patients0.469036
radiation therapy patients0.468456
dry mouth0.687045
neck cancers0.467921
radiation therapy0.972855
Chronic dry mouth0.472069
problems0.532519
regular oral care0.496586
oral care0.520388
peroxide mouth rinses0.475847
PDQ cancer information0.50364
head0.475462
mucous membranes0.503677
mouth moist0.469166
patient0.472618
taste changes0.470678
National Cancer Institute0.465975
summary0.488366
common oral complications0.486948
Wipe mouth0.467118
pain0.536314
white blood cell0.514465
tooth decay0.48102
mouth guards0.465834
gum disease0.504216
salivary glands0.547761
Managing Oral Complications0.485092
PDQ summary0.468583
mouth0.82735
Different oral complications0.468019
milder oral complications0.467906
CLICK HERE
1730 National Cancer Institute Html en Blood-Forming Stem Cell Transplants A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits.
red blood cells0.400014
cancer treatment0.26536
cord blood0.408194
public cord blood0.298389
bone marrow cells0.392639
cord blood bank0.313292
embryonic stem cells0.414015
cord stem cells0.382315
healthy cells0.309763
bone marrow donation0.293131
white blood cells0.53145
transplanted stem cells0.39836
HLA-matched stem cells0.374986
clinical trials0.346744
healthy stem cells0.372316
stem cells0.95315
stem cell transplant0.291072
multiple myeloma0.26697
Bone marrow aspiration0.292859
cord blood banks0.343333
immature cells0.319355
HLA antigens0.259199
appropriate unrelated donor0.262231
radiation therapy0.329306
transplantation0.292216
blood-forming stem cells0.415789
immature nerve cells0.328089
Large volunteer donor0.262362
new blood cells0.334223
blood stem cell0.339528
cancer cells0.404042
special blood test0.260646
peripheral blood stem0.362146
anticancer drugs0.263549
donor0.356002
PBSCT0.299118
patient0.341681
marrow’s ability0.258871
blood stem cells0.413585
healthy bone marrow0.302284
umbilical cord blood0.366965
umbilical cord0.389737
harvested cells0.30119
commercial cord blood0.270418
Marrow Donor Program®0.288844
BMT0.322432
bone marrow0.850438
autologous transplant0.272369
hematopoietic stem cells0.478378
CLICK HERE
1734 National Cancer Institute Html en Diethylstilbestrol (DES) and Cancer A fact sheet about DES (a synthetic form of estrogen) and the health problems of children who were exposed to DES while in the womb.
DES grandsons0.538814
Hatch EE0.382563
DES exposure0.67711
Cell Cancer Registry0.421337
pregnant women0.436903
mothers0.380607
Pap test0.370345
researchers0.371735
pregnancy0.387046
slightly increased risk0.395077
DES Follow-up Study0.632841
DES-exposed women0.392223
health problems0.418784
slightly higher risk0.374572
prenatal DES exposure0.579068
hormone replacement therapy0.402773
possible health effects0.424124
health effects0.485372
women0.613207
DES daughters0.874038
abnormal cells0.390363
overall cancer risk0.3987
prenatally exposed men0.392794
regular breast cancer0.374945
Hormonal Transplacental Carcinogenesis0.419307
third-generation daughters0.375828
DES-exposed daughters0.446699
adverse health effects0.420665
clear cell adenocarcinoma0.541335
unexposed women0.492521
DES granddaughters0.631672
studies0.380945
National Cancer Institute0.372742
Military medical records0.370524
higher risk0.376562
breast cancer risk0.433356
breast cancer0.508269
birth defects0.404912
cervical intraepithelial neoplasia0.371506
DES-exposed mothers0.370151
DES0.962997
squamous intraepithelial lesions0.371888
abnormal cell changes0.370094
Clear Cell Cancer0.418711
et al0.459666
New England Journal0.400964
cancer0.517317
risk0.491261
CLICK HERE
1981 National Cancer Institute Html es Etapa final de la vida (PDQ®)–Versión para pacientes Sumario informativo revisado por expertos sobre el tratamiento y la atención del paciente de cáncer desde los últimos días hasta las últimas horas de vida; esto incluye los síntomas comunes, los dilemas éticos que pueden surgir y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este período.
etapa final0.952722
alientoLa sensación0.303004
siguientes afecciones0.302215
Mejor comunicación0.301527
posibles daños0.30146
Contracciones mioclónicasLas0.30427
siguientes tipos0.302214
PDQ Aflicción0.302895
PDQ Etapa final0.30437
suficiente oxígeno0.302526
HemorragiaLa hemorragia0.303897
vía rectal0.302425
obstructiva crónica0.302498
posibles riesgos0.304519
efectos directos0.302483
vías respiratorias0.375323
muerteEl estertor0.304331
National Cancer Institute0.30139
especial cánceres0.30221
Mejor alivio0.301759
próximas horas0.302343
Instituto Nacional0.302514
PDQ Planificar0.312661
contracciones súbitas0.303377
pequeñas cantidades0.302149
importantes beneficios0.301883
cuánta probabilidad0.301726
Physician Data Query0.305159
LíquidosLos pacientes0.308282
PDQ Fatiga0.306846
FatigaLa fatiga0.303104
PDQ Delirium0.307935
término instrucciones0.301507
posibles beneficios0.301551
nutrición parenteral0.304251
reanimación cardiorrespiratoria0.301653
causa sufrimiento0.302836
Mejor perspectiva0.301742
sufrimiento extremo0.306751
numerosos cambios0.308661
ReanimaciónLos pacientes0.308108
CLICK HERE
16297 National Cancer Institute Html en Medicinal Mushrooms (PDQ®)–Health Professional Version Expert-reviewed information summary about the use of medicinal mushrooms as a treatment for people with cancer.
G. lucidum products0.573204
adjuvant chemotherapy0.660268
PSK-treated group0.523648
class I–negative patients0.557926
control group0.693917
humoral immune parameters0.519217
Baseline immune parameters0.519968
PDQ cancer information0.546523
lung cancer0.659292
investigators0.524722
natural killer0.558674
turkey tail0.569981
innate immune cells0.545469
advanced gastric cancer0.572653
doxorubicin -based chemotherapy0.54683
patients0.832482
cancer patients0.665826
G. lucidum0.844684
gastric cancer patients0.617385
PSK0.985645
adjuvant therapy0.585553
standard cancer treatments0.5637
G. lucidum fruit0.543411
cancer patient plasma0.523542
radiation therapy0.5502
lung cancer models0.542252
medicinal mushrooms0.540839
protein-bound PSK0.737238
immune response pathways0.537187
lung cancer cohort.0.537885
PSK recipients0.737199
PSK adjuvant immunotherapy0.863333
PSK group0.883506
advanced lung cancer0.536376
G. lucidum polysaccharides0.77527
advanced colorectal cancer0.532494
National Cancer Institute0.545709
5-year survival0.544251
direct antitumor mechanisms0.520707
lung cancer patients0.596507
PSK patients0.803579
adjuvant PSK0.861863
gastric cancer0.807983
G. lucidum enhance0.535434
direct antitumor0.521271
PSK treatment0.759609
5-year survival rates0.518116
MHC expression–negative patients0.571654
CLICK HERE
16562 National Cancer Institute Html en Screen to Save: NCI Colorectal Cancer Outreach and Screening Initiative NCI Colorectal Cancer Outreach and Screening Initiative aims to increase colorectal cancer screening rates among ethnically and racially diverse and rural communities nationwide.
NCI-designated Cancer Centers0.680452
country0.523395
evidence-based resources0.584437
education0.537172
National Cancer Advisory0.70446
Alaskan Natives0.584304
recommendations0.526636
overall assessment0.573123
ethnically diverse communities0.720461
local communities0.586899
colorectal screening rates0.853048
outreach activities0.578711
colorectal cancer screening0.850894
rural areas0.584762
colorectal cancer0.992617
Cancer Control National0.675464
PACHE-funded community health0.657281
community levels0.588626
National Outreach Network0.661026
Health Disparities Program0.668335
women age0.582977
Reduce Cancer Health0.704459
American Indians0.579831
Colorectal Cancer Awareness0.761387
Cancer Moonshot0.620655
Cancer Health Disparities0.821429
NCI Center0.608436
Blacks/African Americans0.579578
Save initiative0.611204
Cancer Health Equity0.685373
NCI Colorectal Cancer0.830393
Regional Coordinating Directors0.639583
diverse partner network0.664475
Blue Ribbon Panel0.662084
rural communities0.646304
Geographic Management0.573805
community health educators0.957975
outreach efforts0.576306
Native Hawaiians0.58859
screening resources0.639461
Pacific Islanders0.584476
evidence-based colorectal cancer0.788139
key role0.575779
colorectal screening behaviors0.792179
NCI-approved colorectal cancer0.776303
additional community engagements0.645113
Screening Initiative0.658551
information0.537846
CLICK HERE
16713 National Cancer Institute Html es Iniciativa de Respuestas Excepcionales: Preguntas y respuestas El Instituto Nacional del Cáncer (NCI) emprendió la Iniciativa de Respuestas Excepcionales a fin de entender la base molecular de los tumores en pacientes de cáncer que responden en forma excepcional al tratamiento, principalmente quimioterapia.
Exceptional Responders0.786989
suficiente información0.61563
Sequencing Identifies0.586522
poderosa técnica0.577603
tejido no puede usarse para otras0.723672
siguientes criterios0.611344
llamado data access request0.624892
ARN mensajero0.581431
Everolimus Sensitivity0.593577
suficiente ácido0.633822
Genome Sequencing0.743091
suficiente tejido0.888254
genes tsc10.601267
datos dbGAP0.580415
estudio piloto0.664379
tejido fijo en formol0.691726
Exceptional Responders Data0.636284
Exceptional Responders Initiative0.702067
consentimiento apropiado para investigaciones0.678722
fármacos similares. El estudio0.741131
Instituto Nacional0.57833
gen tsc10.738554
Trials Support Unit0.638511
descubrimientos prometedores0.585883
datos clínicos a medidata0.649717
Revisión Central de Adultos0.624848
extensa experiencia0.580712
requiere varios pasos0.583341
pacientes con respuestas0.618767
centro biospecimen core0.880872
tumores sólidos0.758056
enfermedad y el0.583796
aun pacientes0.751408
CLICK HERE
17189 National Cancer Institute Html en Sexual Health Issues in Women with Cancer Cancer treatments such as chemotherapy, hormone therapy, and radiation may cause sexual problems in women. Conditions may include vaginal dryness, vaginal stenosis, and vaginal atrophy. Learn how to manage and treat these sexual problems.
cancer treatment0.51645
vaginal tissue0.532819
primary ovarian insufficiency0.548774
endocrine therapy0.478386
health care team0.776749
sexual life0.612375
support group0.540233
gynecologic cancers0.477639
social worker0.530013
pelvic muscles0.474973
sexual activity0.559668
sexual health0.668647
sexual intercourse0.555683
low estrogen levels0.65848
hair loss0.473268
physical changes0.478751
birth control0.564552
Fertility Issues0.55759
effects0.479305
sexual problems0.5327
hot flashes0.548172
radiation therapy0.542011
long term0.480571
valuable suggestions0.473342
vaginal dryness0.649951
vaginal gels0.527917
problems0.541005
women0.505517
cancer treatments0.472282
treatment0.973526
sex life0.471664
personal health factors0.547006
vaginal secretions0.525892
cancer-related support services0.536181
changes0.511207
Vaginal stenosis0.532538
vaginal wall0.531486
vaginal atrophy0.531565
hormone therapy0.536753
sexual changes0.501579
bladder retention0.472634
shorter vagina0.48061
sexual health expert0.553722
support groups0.47572
Breast Cancer0.475837
doctor0.494029
bowel function0.475187
national organizations0.470856
time0.509374
CLICK HERE
17222 National Cancer Institute Html en Tumor DNA Sequencing in Cancer Treatment Tumor DNA sequencing (also called genetic profiling or genetic testing) is a test to identify DNA changes in a patient’s cancer. In some cases, this information can help determine a treatment plan.
unique DNA changes0.327494
health care provider0.21495
lung tumor0.253938
tumor sequencing0.343527
specific genetic alterations0.302101
healthy cells0.230873
Multigene panel tests0.208409
health care team0.2107
frequently used sequencing0.320207
hereditary cancer syndromes0.221971
health care providers0.211937
whole-genome sequencing0.314537
cancer types0.228448
DNA changes0.331071
patient care0.205253
targeted sequencing tests0.342426
broad tumor DNA0.375946
heterogeneous tumor0.233471
DNA sequencing tests0.507176
precision medicine0.222532
single cancer type0.228039
lung cancer cells0.3596
treatment0.286045
precision medicine trials0.205063
DNA alteration0.251455
NCI-COG Pediatric MATCH0.207207
inherited genetic alteration0.228682
DNA sequence0.253453
cancer cells0.454035
unique genetic alterations0.280668
sequencing tests cost0.308627
EGFR mutation0.209321
Broad DNA sequencing0.411749
cancer-causing DNA changes0.297683
way cells function0.250384
tumor dna0.91525
tumor dna sequencing0.748819
DNA sequencer0.254089
Clinical tumor DNA0.406068
health care0.275099
DNA sequencing test0.405098
mRNA expression test0.209986
breast cancer0.203535
genetic alterations0.703142
cancer0.512553
standard treatment0.204466
whole-exome sequencing0.314247
quantitative mRNA test0.208612
CLICK HERE
17290 National Cancer Institute Html es Uso extraoficial de medicamentos en el tratamiento del cáncer Conozca qué es el uso extraoficial o no indicado de medicamentos y el papel que desempeña en el tratamiento del cáncer.
régimen r-cvp0.716896
régimen cmf0.714486
régimen beacopp0.710604
amplio uso0.781419
Estados Unidos0.77621
seguro médico0.921249
siguientes razones0.728265
régimen tac0.710628
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.